BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Karolinska Development AB 

Fogdevreten 2, Solna

Stockholm    S-171 77  Sweden
Phone: 46-0-8-524-865-91 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






 Company News
Chiltern International Ltd. Partners With Karolinska Development AB 2/12/2014 9:15:36 AM    More...
Karolinska Development AB: Lipidor Reports Positive Clinical Phase I/II Data in Psoriasis 8/27/2013 10:26:57 AM    More...
Karolinska Development AB Interim report January - June 2013 8/22/2013 9:52:26 AM    More...
Karolinska Development AB (publ) -- Interim report January - June 2013 8/22/2013 6:52:24 AM    More...
Karolinska Development AB: Pharmanest Meets All Efficacy and Safety End Points in Phase II Study of SHACT 8/1/2013 9:16:55 AM    More...
Karolinska Development AB: Pergamum Reports Positive Follow-Up Data From a Phase II Clinical Trial of PXL-01 for Prevention of Post-Surgical Adhesions 6/27/2013 10:38:33 AM    More...
Karolinska Development AB: EU Grants EUR 6 Million to the Clinical Development of Athera Biotechnologies' Cardiovascular Disease Antibody Therapy 6/17/2013 9:28:38 AM    More...
Karolinska Development AB: First Patient Dosed in the Phase I/II Study of Umecrine Mood's Candidate Drug for Premenstrual Dysphoric Disorder 5/23/2013 10:52:45 AM    More...
Karolinska Development AB - Interim Report January - March 2013 5/10/2013 9:38:37 AM    More...
Karolinska Development AB (publ) - Interim Report January - March 2013 5/10/2013 8:00:09 AM    More...
1234

//-->